CrystalGenomics, Inc. - Product Pipeline Review - 2016

Publisher Name :
Date: 31-Aug-2016
No. of pages: 37
Inquire Before Buying

CrystalGenomics, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct's, ‘CrystalGenomics, Inc. - Product Pipeline Review, 2016', provides an overview of the CrystalGenomics, Inc.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by CrystalGenomics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of CrystalGenomics, Inc.

- The report provides overview of CrystalGenomics, Inc. including its business description, key facts, and locations and subsidiaries

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report assesses CrystalGenomics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report features CrystalGenomics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate CrystalGenomics, Inc.'s strategic position with total access to detailed information on its product pipeline

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for CrystalGenomics, Inc.

- Identify potential new clients or partners in the target demographic

- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding CrystalGenomics, Inc.'s pipeline depth and focus of pipeline therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

CrystalGenomics, Inc. - Product Pipeline Review - 2016

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
CrystalGenomics, Inc. Snapshot 5
CrystalGenomics, Inc. Overview 5
Key Information 5
Key Facts 5
CrystalGenomics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
CrystalGenomics, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
CrystalGenomics, Inc. - Pipeline Products Glance 12
CrystalGenomics, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
CrystalGenomics, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
CrystalGenomics, Inc. - Drug Profiles 16
CG-400549 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
CG-200745 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
CG-026806 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
CG-036806 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
polmacoxib 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
CG-0009 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Small Molecule to Target Metalloproteinases for Undisclosed Indication 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Small Molecule to Target Nuclear Hormone Receptors for Undisclosed Indication 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Small Molecule to Target Phosphodiesterases for Undisclosed Indication 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
CrystalGenomics, Inc. - Pipeline Analysis 26
CrystalGenomics, Inc. - Pipeline Products by Target 26
CrystalGenomics, Inc. - Pipeline Products by Route of Administration 28
CrystalGenomics, Inc. - Pipeline Products by Molecule Type 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action 30
CrystalGenomics, Inc. - Recent Pipeline Updates 31
CrystalGenomics, Inc. - Dormant Projects 34
CrystalGenomics, Inc. - Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 36
Disclaimer 37

List of Tables
CrystalGenomics, Inc., Key Information 5
CrystalGenomics, Inc., Key Facts 5
CrystalGenomics, Inc. - Pipeline by Indication, 2016 7
CrystalGenomics, Inc. - Pipeline by Stage of Development, 2016 8
CrystalGenomics, Inc. - Monotherapy Products in Pipeline, 2016 9
CrystalGenomics, Inc. - Partnered Products in Pipeline, 2016 10
CrystalGenomics, Inc. - Partnered Products/ Combination Treatment Modalities, 2016 11
CrystalGenomics, Inc. - Phase II, 2016 12
CrystalGenomics, Inc. - Phase I, 2016 13
CrystalGenomics, Inc. - Preclinical, 2016 14
CrystalGenomics, Inc. - Discovery, 2016 15
CrystalGenomics, Inc. - Pipeline by Target, 2016 27
CrystalGenomics, Inc. - Pipeline by Route of Administration, 2016 28
CrystalGenomics, Inc. - Pipeline by Molecule Type, 2016 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action, 2016 30
CrystalGenomics, Inc. - Recent Pipeline Updates, 2016 31
CrystalGenomics, Inc. - Dormant Developmental Projects,2016 34
CrystalGenomics, Inc., Subsidiaries 35

List of Figures
CrystalGenomics, Inc. - Pipeline by Top 10 Indication, 2016 7
CrystalGenomics, Inc. - Pipeline by Stage of Development, 2016 8
CrystalGenomics, Inc. - Monotherapy Products in Pipeline, 2016 9
CrystalGenomics, Inc. - Pipeline by Target, 2016 26
CrystalGenomics, Inc. - Pipeline by Route of Administration, 2016 28
CrystalGenomics, Inc. - Pipeline by Molecule Type, 2016 29
CrystalGenomics, Inc. - Pipeline Products by Mechanism of Action, 2016 30
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Biochar Market Report 2017
    Published: 04-Apr-2017        Price: US 4000 Onwards        Pages: 124
    In this report, the EMEA Biochar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Biochar for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Middle East: Saudi ......
  • Biopharmaceuticals Markets in China
    Published: 18-Mar-2017        Price: US 4000 Onwards        Pages: 233
    China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • Biopharmaceuticals Industry Forecasts - China Focus
    Published: 18-Mar-2017        Price: US 1800 Onwards        Pages: 90
    This study focuses on China's Biopharmaceuticals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services. ......
  • Biopharmaceuticals Companies in China
    Published: 18-Mar-2017        Price: US 1800 Onwards        Pages: 96
    This study focuses on China's Biopharmaceuticals industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions ......
  • Actelion Partnering Deals and Alliances 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary This report provides all the information you require to better understand Actelion and its partnering interests and activities since 2010 The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. On demand company reports are prepared upon purchase to ensure inclusi......
  • Alkermes Partnering Deals and Alliances 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary This report provides all the information you require to better understand Alkermes and its partnering interests and activities since 2010 The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. On demand company reports are prepared upon purchase to ensure inclusi......
  • Amylin Pharmaceuticals Partnering Deals and Alliances 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary This report provides all the information you require to better understand Amylin Pharmaceuticals and its partnering interests and activities since 2010 The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. On demand company reports are prepared upon purchase to ......
  • AstraZeneca Partnering Deals and Alliances 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary This report provides all the information you require to better understand AstraZeneca and its partnering interests and activities since 2010. The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. On demand company reports are prepared upon purchase to ensure inc......
  • Biocon Partnering Deals and Alliances 2010 to 2017
    Published: 01-Mar-2017        Price: US 1495 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." Summary This report provides all the information you require to better understand Biocon and its partnering interests and activities since 2010. The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. On demand company reports are prepared upon purchase to ensure inclusio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs